KCNF2 (Potassium Voltage-Gated Channel Modulator Subfamily F Member 2) encodes the Kv5.2 protein, a modulatory subunit that influences the function of voltage-gated potassium channels, particularly Kv2.1. While KCNF2 does not form functional channels on its own, it dramatically modulates the trafficking, gating, and expression of partner potassium channels. This modulatory function has significant implications for neuronal excitability, synaptic transmission, and ultimately for neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and epilepsy. [1]
KCNF2 encodes a 446-amino acid protein primarily expressed in the brain, heart, and kidney. The protein localizes to the plasma membrane and associates with voltage-gated potassium channels, particularly the Kv2.1 (KCNB1) channel. Through this interaction, KCNF2 modulates channel properties including activation voltage, inactivation kinetics, and surface expression. The gene is located on chromosome 5q31.1. [2]
| Property | Value | [3]
|----------|-------| [4]
| Gene Symbol | KCNF2 | [5]
| Full Name | Potassium Voltage-Gated Channel Modulator Subfamily F Member 2 |
| Chromosomal Location | 5q31.1 |
| NCBI Gene ID | 58484 |
| Ensembl ID | ENSG00000157119 |
| UniProt ID | Q96T59 |
| Protein Length | 446 amino acids |
| Expression | Brain (highest), heart, kidney |
KCNF2 belongs to the Kv channel modulator family (KCNF1-5), which share:
KCNF2 modulates potassium channels through several mechanisms:
In neurons, KCNF2 and its partner channels regulate:
KCNF2 connections to AD:
Potential PD connections:
KCNF2 and related channels in epilepsy:
KCNF2 interacts with:
The study of Kcnf2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Kurata, H.T., & Nichols, C.G. (2013). KATP channel dysfunction in cardiac disease. J Mol Cell Cardiol. 2013. ↩︎
Rudy, B., & McBain, C.J. (2001). Kv3 channels: voltage-gated K+ channels designed for high-frequency repetitive firing. Trends Neurosci. 2001. ↩︎
Bean, B.P. (2007). The action potential in mammalian central neurons. Nat Rev Neurosci. 2007. ↩︎